carvedilol has been researched along with Skin Neoplasms in 4 studies
Skin Neoplasms: Tumors or cancer of the SKIN.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 2 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, Q | 1 |
| Long, J | 1 |
| Hu, L | 1 |
| Chen, Z | 1 |
| Li, Q | 1 |
| Hu, G | 1 |
| Abdullah Shamim, M | 1 |
| Yeung, S | 2 |
| Shahid, A | 1 |
| Chen, M | 1 |
| Wang, J | 1 |
| Desai, P | 1 |
| Parsa, C | 2 |
| Orlando, R | 2 |
| Meyskens, FL | 1 |
| Kelly, KM | 1 |
| Andresen, BT | 3 |
| Huang, Y | 3 |
| Cleveland, KH | 1 |
| Liang, S | 1 |
| Chang, A | 2 |
| Huang, KM | 2 |
| Chen, S | 1 |
| Guo, L | 1 |
| Thakkar, A | 1 |
| Liu, MM | 1 |
| Kanassatega, RS | 1 |
| Jackson, EK | 1 |
4 other studies available for carvedilol and Skin Neoplasms
| Article | Year |
|---|---|
Drug repurposing and rediscovery: Design, synthesis and preliminary biological evaluation of 1-arylamino-3-aryloxypropan-2-ols as anti-melanoma agents.
Topics: Antineoplastic Agents; Apoptosis; Cell Proliferation; Cell Survival; Dose-Response Relationship, Dru | 2020 |
Topical carvedilol delivery prevents UV-induced skin cancer with negligible systemic absorption.
Topics: Absorption, Physiological; Animals; Carvedilol; Mice; Pharmaceutical Preparations; Skin Neoplasms; S | 2022 |
Carvedilol inhibits EGF-mediated JB6 P+ colony formation through a mechanism independent of adrenoceptors.
Topics: Adrenergic beta-Antagonists; Alprenolol; Animals; Carvedilol; Cell Line; Cell Proliferation; Cell Tr | 2019 |
Prevention of skin carcinogenesis by the β-blocker carvedilol.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Adrenergic beta-Antagonists; Animals; Anticarcinogenic Agents; Ate | 2015 |